摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2',4'-dimethoxy-4-nitro-[1,1'-biphenyl]-2-carboxylate | 1026777-98-9

中文名称
——
中文别名
——
英文名称
methyl 2',4'-dimethoxy-4-nitro-[1,1'-biphenyl]-2-carboxylate
英文别名
methyl 2-(2,4-dimethoxyphenyl)-5-nitrobenzoate
methyl 2',4'-dimethoxy-4-nitro-[1,1'-biphenyl]-2-carboxylate化学式
CAS
1026777-98-9
化学式
C16H15NO6
mdl
——
分子量
317.298
InChiKey
SSUWZYLEMAEAPP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    90.6
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 2',4'-dimethoxy-4-nitro-[1,1'-biphenyl]-2-carboxylate 在 palladium 10% on activated carbon 氢气三溴化硼 作用下, 以 甲醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, -78.0~20.0 ℃ 、294.21 kPa 条件下, 反应 1.0h, 生成 8-amino-3-hydroxy-6H-benzo[c]chromen-6-one
    参考文献:
    名称:
    GLUCOCORTICOID RECEPTOR AGONIST COMPOSED OF 2,2,4-TRIMETHYL-6-PHENYL-1,2-DIHYDROQUINOLINE DERIVATIVE HAVING SUBSTITUTED OXY GROUP
    摘要:
    公开号:
    EP2319835B1
  • 作为产物:
    描述:
    3-methoxy-8-nitro-6H-benzo[c]chromen-6-one 在 四丁基溴化铵 、 sodium hydroxide 作用下, 以 四氢呋喃甲醇二氯甲烷 为溶剂, 反应 24.01h, 生成 methyl 2',4'-dimethoxy-4-nitro-[1,1'-biphenyl]-2-carboxylate
    参考文献:
    名称:
    Donor–acceptor biaryl lactones: pH induced molecular switches with intramolecular charge transfer modulation
    摘要:
    The physical properties of biaryl-containing compounds are known to be highly dependent on molecular geometry. We report the syntheses and fundamental spectroscopic study of two donor-acceptor biaryl lactone (6H-benzo[c]chromen-6-one) pH-driven switches. These compounds have been determined to rapidly and efficiently switch between two geometric states upon cycling of acidic or basic stimuli. The planar lactone state exhibits enhanced intramolecular charge transfer (ICT) between the donor and acceptor units which is instantly attenuated upon addition of basic stimuli. The resulting lactone cleavage enables aryl-aryl bond rotation thus decreasing the extent of conjugation between the rings. Each state is readily identifiable by the significant changes that occur in their respective UV-vis spectra and luminescent character, indicative of the facile modulation of extended conjugation by pH. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.09.016
点击查看最新优质反应信息

文献信息

  • NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING (SUBSTITUTED PHENYL OR SUBSTITUTED HETEROCYCLIC) CARBONYLOXY LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS
    申请人:Matsuda Mamoru
    公开号:US20090298826A1
    公开(公告)日:2009-12-03
    The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator. The R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom or a lower alkyl group; R 3 and R 4 may be the same or different and represent a hydrogen atom or a lower alkyl group; R 5 represents a hydrogen atom or a lower alkyl group; R 6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR 8 —, —S(O) 2 — and the like; R 7 and/or R 8 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; Z represents a benzene ring or a heterocyclic ring; and P represents 0, 1, 2 or 3.
    通用公式(1)中代表的化合物及其盐对糖皮质激素受体调节剂非常有用。其中,R1代表氢原子或较低的烷基基团;R2代表氢原子或较低的烷基基团;R3和R4可以相同也可以不同,代表氢原子或较低的烷基基团;R5代表氢原子或较低的烷基基团;R6代表卤素原子、较低的烷基基团、羟基、较低的烷氧基、硝基或氰基;X代表—C(O)—、—C(O)NR8—、—S(O)2—等;R7和/或R8可以相同也可以不同,代表氢原子、可能具有取代基团的较低烷基基团、可能具有取代基团的芳基、可能具有取代基团的杂环基团、可能具有取代基团的较低烷氧基团等;Y代表较低的烷基烯基团;Z代表苯环或杂环环;P代表0、1、2或3。
  • NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING SUBSTITUTED PHENYLAMINO LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS
    申请人:Matsuda Mamoru
    公开号:US20090298827A1
    公开(公告)日:2009-12-03
    The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator. The R 1 represents a hydrogen atom or a lower alkyl group; R 2 represents a hydrogen atom or a lower alkyl group; R 3 and R 4 may be the same or different and represents a hydrogen atom or a lower alkyl group; R 5 represents a hydrogen atom or a lower alkyl group; R 6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR 8 —, —S(O) 2 — and the like; R 7 and/or R 8 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; and P represents 0, 1, 2 or 3.
    通式(1)及其盐对于糖皮质激素受体调节剂很有用。其中,R1代表氢原子或较低烷基;R2代表氢原子或较低烷基;R3和R4可以相同也可以不同,代表氢原子或较低烷基;R5代表氢原子或较低烷基;R6代表卤原子、较低烷基、羟基、较低烷氧基、硝基或氰基;X代表—C(O)—,—C(O)NR8—,—S(O)2—等;R7和/或R8可以相同也可以不同,代表氢原子、较低烷基(可能具有取代基)、芳基(可能具有取代基)、杂环基(可能具有取代基)、较低烷氧基(可能具有取代基)等;Y代表较低烷基烯基;P代表0、1、2或3。
  • Method for preventing or treating a disease related to the glucocorticoid receptor
    申请人:Matsuda Mamoru
    公开号:US20110275620A1
    公开(公告)日:2011-11-10
    A method for preventing or treating a disease related to the glucocorticoid receptor involving administering a pharmacologically effective amount of a 1,2-hydroquinoline compound.
    一种预防或治疗与糖皮质激素受体相关的疾病的方法,涉及给予1,2-羟基喹啉化合物的药理有效剂量。
  • 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
    申请人:Santen Pharmaceutical Co., Ltd.
    公开号:US08008498B2
    公开(公告)日:2011-08-30
    The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator. The R1 represents a hydrogen atom or a lower alkyl group; R2 represents a hydrogen atom or a lower alkyl group; R3 and R4 may be the same or different and represents a hydrogen atom or a lower alkyl group; R5 represents a hydrogen atom or a lower alkyl group; R6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR8—, —S(O)2— and the like; R7 and/or R8 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; and P represents 0, 1, 2 or 3.
    通式(1)所代表的化合物及其盐对于糖皮质激素受体调节剂很有用。其中,R1代表氢原子或较低的烷基;R2代表氢原子或较低的烷基;R3和R4可以相同也可以不同,代表氢原子或较低的烷基;R5代表氢原子或较低的烷基;R6代表卤原子、较低的烷基、羟基、较低的烷氧基、硝基或氰基;X代表—C(O)—、—C(O)NR8—、—S(O)2—等;R7和/或R8可以相同也可以不同,代表氢原子、较低的烷基(可能有取代基)、芳基(可能有取代基)、杂环基(可能有取代基)、较低的烷氧基(可能有取代基)等;Y代表较低的烷基;P代表0、1、2或3。
  • 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
    申请人:Santen Pharmaceutical Co., Ltd.
    公开号:US08008497B2
    公开(公告)日:2011-08-30
    The compounds represented in general formula (1) and a salt thereof are useful for glucocorticoid receptor modulator. The R1 represents a hydrogen atom or a lower alkyl group; R2 represents a hydrogen atom or a lower alkyl group; R3 and R4 may be the same or different and represent a hydrogen atom or a lower alkyl group; R5 represents a hydrogen atom or a lower alkyl group; R6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X represents —C(O)—, —C(O)NR8—, —S(O)2— and the like; R7 and/or R8 may be the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, a lower alkoxy group which may have a substituent and the like; Y represents a lower alkylene group; Z represents a benzene ring or a heterocyclic ring; and P represents 0, 1, 2 or 3.
    通式(1)所代表的化合物及其盐对于糖皮质激素受体调节剂非常有用。其中,R1代表氢原子或较低的烷基;R2代表氢原子或较低的烷基;R3和R4可以相同也可以不同,代表氢原子或较低的烷基;R5代表氢原子或较低的烷基;R6代表卤原子、较低的烷基、羟基、较低的烷氧基、硝基或氰基;X代表-C(O)-、-C(O)NR8-、-S(O)2-等;R7和/或R8可以相同也可以不同,代表氢原子、较低的烷基(可能有取代基)、芳基(可能有取代基)、杂环基(可能有取代基)、较低的烷氧基(可能有取代基)等;Y代表较低的烷基;Z代表苯环或杂环环;P代表0、1、2或3。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐